Improved skin hydration and surface glow The most reliable benefit, visible within days of the first session and developing over the course
Why Protein Intake Matters When Using Retatrutide or GLP-1 Medications GLP-1 receptor agonists and triple-agonist therapies like retatrutide often create a noticeable behavioral feedback loop
GLP-1 receptor agonists and risk of neurodegenerative disease: nationwide register study
In patients with T2D combined with arteriosclerotic cardiovascular disease (ASCVD) or very high cardiovascular risk, GLP-1 RAs have been recommended as one of the preferred combined medications
Pena I, Clayman GL, Grubbs EG, Bergeron JM, Waguespack SG, Cabanillas ME, Dadu R, Hu MI, Fellman BM, Li Y, Gross ND, Lai SY, Sturgis EM, Zafereo ME